When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DNLI - Early-stage study of Denali's Alzheimer's candidate DNL747 underway; shares up 1% premarket
Denali Therapeutics Inc.
Dosing is underway in a Phase 1b clinical trial evaluating Denali Therapeutics' (NASDAQ:DNLI) DNL747 in Alzheimer's disease patients. The primary objectives are safety and biomarker data which will inform future studies.
More news on: Denali Therapeutics, Inc., Sanofi, Healthcare stocks news, Stocks on the move,